FRAMINGHAM, Mass. — SCIEX, a global leader in life science analytical technologies, has released the results of an independent survey of clinical laboratories’ diagnostic technology usage that identifies a critical need for improved understanding of clinical mass spectrometry technology. The worldwide survey investigated the most commonly used diagnostic methods, technologies and assay types, and identified […]
OMAHA, Neb.– Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced that it is planning to launch up to six new genetic cancer tests this year based on its Multiplexed ICE COLD-PCR™ (MX-ICP) technology. The new tests will focus on actionable genetic […]
MOUNTAIN VIEW, Calif. – DNAnexus, a leader in genome informatics and data management, today announced a collaboration with The Human Genome Sequencing Center (HGSC) at Baylor College of Medicine, a world leader in large-scale sequencing and analysis solutions, to co-develop HgV, the next generation of the HGSC’s Mercury solutions pipeline. HgV is a comprehensive framework […]
TOKYO, Japan and HILDEN, Germany – Hitachi High-Technologies Corporation (TSE:8036) and QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have entered into a long-term strategic collaboration involving initiatives to deliver important advances in molecular testing. Under terms of the agreement, both companies will bring their unique strengths to the collaboration: Hitachi High-Technologies is recognized as […]
Lausanne, Switzerland – Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, and Spinomix, a Swiss technology platform company providing innovative sample processing solutions to the life sciences sector, today announced the acquisition by Debiopharm of Spinomix’ FibroTrap sample processing technology. Commercial terms of the transaction were not disclosed. FibroTrap is […]
Ipswich, MA – With the goal of better serving its customers in more regulated markets, New England Biolabs (NEB®) today announced plans to build capacity for manufacturing enzymes and other reagents according to good manufacturing practices (GMP), which are standards for materials involved in the manufacture of human therapeutics and molecular diagnostics. The plans include […]
SINGAPORE – A*STAR’s Genome Institute of Singapore (GIS) has established a strategic joint laboratory initiative with Pyrobett Pte Ltd, a Singapore-based joint venture between BMS[1]and QIAGEN[2] to develop a pyrosequencing platform for clinical diagnostics. Located within the same building as GIS, the new GIS-Pyrobett laboratory is in line with GIS’ global vision to use genomic […]
Newcastle-Upon-Tyne, England and Berlin, Germany — QMDx utilises SCIENION’s proprietary ultra-low volume liquid handling technologies to transfer biological material onto QMDx’s novel biosensor. Each nanowire in the array is printed with molecular probes; with hundreds of nanowires in each silicon biosensor chip, the multiplexing potential is massive. The companies’ longstanding relationship was cemented with QMDx’s […]
OMAHA, Neb. -— Transgenomic, Inc. (NASDAQ: TBIO), a developer of the most flexible, sensitive and robust platform for liquid biopsies on the market, today announced that Mya Thomae has been named to its Board of Directors and Harjit Kullar, PhD, has been appointed Vice President of Marketing for the Biomarker Discovery and Genetic Assays and […]
AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) today announced that it has commenced clinical and analytical studies to evaluate the company’s ARIES™ Group B Streptococcus (GBS) Assay. ARIES System “We continue to build momentum in our commercial launch schedule for the ARIES platform with the start of clinical trials for GBS, the third assay in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
